This clinical trial aims to determine if the type of intravenous fluid used for initial resuscitation affects the short-term outcomes of adult patients with sepsis who are treated in the emergency department.
The main questions it aims to answer are:
Does using Ringer's lactate instead of 0.9% sodium chloride (normal saline) reduce 24-hour mortality in patients with sepsis?
Does the type of fluid influence other short-term outcomes, such as the need for vasopressors, mechanical ventilation, hemodialysis, and length of hospital stay?
Researchers will compare two groups of participants:
* The Ringer's lactate group (intervention group)
* The 0.9% sodium chloride group (control group).
Participants will:
* Receive either Ringer's lactate or normal saline for initial fluid resuscitation as part of standard sepsis care.
* They will be observed for 24 hours to assess survival and other early outcomes.